Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1985;7:53-58

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seino, M.
Right arrow Articles by Yoshinaga, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seino, M.
Right arrow Articles by Yoshinaga, K.

Hypertension, Vol 7, 53-58, Copyright © 1985 by American Heart Association


ARTICLES

Interaction of vasopressin and prostaglandins through calcium ion in the renal circulation

M Seino, K Abe, K Tsunoda and K Yoshinaga

To determine whether the effects of arginine vasopressin (AVP) on the renal and systemic vessels are modulated by prostaglandins (PGs), AVP (10, 20, and 50 mU/kg/min) was infused into the renal artery before and after treatment with indomethacin (8 mg/kg) in anesthetized rabbits. Arginine vasopressin elicited a dose-dependent increase in systemic arterial pressure and renal vasoconstriction. However, after cessation of the infusion, significant renal vasodilation was observed. Indomethacin potentiated the systemic and renal vasoconstrictor actions and attenuated the renal vasodilator reaction induced by AVP. These results suggest that endogenously produced PGs buffer the vasoconstrictor action of AVP, and the renal vasodilator reaction induced by AVP could be mediated through PGs. Further, to investigate whether the effects of AVP on the systemic and renal vessels are mediated by calcium ion (Ca++), the Ca++ entry blocker nifedipine was used. Intravenous administration of nifedipine (50 micrograms/kg) attenuated the systemic and renal vasoconstrictor action of AVP. The renal vasodilator reaction induced by AVP was also diminished after treatment with nifedipine. These results indicate that the systemic and renal vasoconstrictor actions of AVP are mediated through Ca++ influx into the vascular smooth muscle cells. The present study suggests that Ca++ participates in the AVP-induced vasodilator reaction, itself probably mediated by PGs.


This article has been cited by other articles:


Home page
Exp PhysiolHome page
K. K. Ebenezar, F. S. Ghane, and F. G. Smith
Placental-Perinatal: Effects of indomethacin on systemic and renal haemodynamics in conscious lambs
Exp Physiol, May 1, 2007; 92(3): 575 - 581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. W. Fallet, H. Ikenaga, J. P. Bast, and P. K. Carmines
Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin
Am J Physiol Renal Physiol, March 1, 2005; 288(3): F545 - F551.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. J. Feng and W. J. Arendshorst
Calcium Signaling Mechanisms in Renal Vascular Responses to Vasopressin in Genetic Hypertension
Hypertension, November 1, 1997; 30(5): 1223 - 1231.
[Abstract] [Full Text]